Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Regulatory Filings 2021

Jul 15, 2021

59231_rns_2021-07-15_3955242b-4311-428c-b0c1-444ef918bb7a.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

15[th] July, 2021

==> picture [167 x 46] intentionally omitted <==

BSE Limited National Stock Exchange of India Limited Corporate Relations Department Exchange Plaza P J Towers Bandra Kurla Complex Dalal Street Bandra (E) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 532300 NSE Symbol: WOCKPHARMA

Dear Sir/Madam,

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the Exchanges that a meeting of the Board of Directors of the Company will be held on 22[nd] July, 2021, inter-alia , to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30[th] June, 2021.

Further, pursuant to Company's code of conduct for regulating, monitoring, reporting trading by designated persons and as informed vide letter dated 30[th] June, 2021, the Trading window for dealing in the Shares of the Company has been closed from 1[st] July, 2021 and shall remain closed till 24[th] July, 2021. The Trading Window shall re-open with effect from 25[th] July, 2021.

Kindly take the above information on record.

Thanking you,

for Wockhardt Limited

==> picture [114 x 43] intentionally omitted <==

Gajanand Sahu Company Secretary

==> picture [106 x 46] intentionally omitted <==

==> picture [482 x 30] intentionally omitted <==